SCHEMBL30168595

SCHEMBL30168595

CO/C=C(\Oc1cc(/C(C)=N/OCc2ccccc2C)ccc1C)C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.42
PPARA Q07869 8/20 0.42
MAOB P27338 1/20 0.37
HIF1A Q16665 1/20 0.37
PPARD Q03181 3/20 0.36
KMT2A Q03164 2/20 0.35
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CASP3 P42574 1/20 0.34
HTT P42858 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
S1PR1 P21453 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8024495 0.89 PPARG (0.45) PPARGPPARAPPARDS1PR1SMN1; SMN2
SCHEMBL30168591 0.89 PPARG (0.45) PPARGPPARAPPARDS1PR1SMN1; SMN2
SCHEMBL8024497 0.89 PPARG (0.45) PPARGPPARAPPARDS1PR1SMN1; SMN2
SCHEMBL30168594 0.85 NPC1 (0.41) PPARGPPARAMAOBMAPTKDM4E
SCHEMBL21675869 0.85 NPC1 (0.41) PPARGPPARAMAOBMAPTKDM4E
SCHEMBL8020369 0.82 PPARG (0.39) PPARGPPARAMAPTLMNAKDM4E
SCHEMBL8023016 0.82 PPARG (0.39) PPARGPPARAHIF1APPARDKMT2A
SCHEMBL8020365 0.82 PPARG (0.39) PPARGPPARAMAPTLMNAKDM4E
SCHEMBL8024500 0.81 PPARG (0.46) PPARGPPARAS1PR1SMN1; SMN2
SCHEMBL8026204 0.80 PPARG (0.44) PPARGPPARAS1PR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US claimed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US claimed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US claimed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US claimed
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US disclosed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US disclosed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD MT-CO3, MT-CO2, HADHB PPARG 2080/4885PPARA 3382/4885MAOB 370/4885
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD FASTKD1, MT-CO1, MT-CO2 PPARG 417/4885PPARA 718/4885MAOB 207/4885
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD CYP51A1, CTRL, ERG28 PPARG 1078/4885PPARA 1995/4885MAOB 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.